Secondary Infusion of Relma-cel Injection for Relapsed or Refractory B-cell Lymphoma
Clinical trial NCT05806580 · RECRUITING
Trial details
- NCT number
- NCT05806580
- Sponsor
- Ruijin Hospital
- Status
- RECRUITING
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2023-05-01
- Primary completion
- 2027-05-31
- Enrollment
- 8
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.